U-Lite Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per sachet Na bicarbonate 1.76 g, citric acid 0.72 g, Na citrate 0.63 g, tartaric acid 0.89 g

Indications/Uses

Relief of burning discomfort caused by mild UTI. Reduce formation of uric acid & cystine calculi in chronic gout. Enhance action of certain antibiotics eg, sulfonamide. Symptomatic relief of gastric hyperacidity.

Click to view U-Lite detailed prescribing information

Dosage/Direction for Use

1-2 sachets qds.

Click to view U-Lite detailed prescribing information

Overdosage

View U-Lite overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Dissolve content in a glass of water.

Contraindications

Hypernatremia, overt & occult cardiac failure, severe myocardial damage, resp alkalosis, hypocalcemia, hypochloremia, hypochlorhydria, Addison's disease, acute dehydration, heat cramps. Not recommended in concomitant use w/ hexamine mandelate or hippurate therapy. Avoid concomitant use of urinary alkalinisers & quinolone antibiotics. Severe renal impairment or renal failure.

Click to view U-Lite detailed prescribing information

Special Precautions

HTN, heart failure, peripheral or pulmonary oedema, pre-eclampsia or other conditions associated w/ Na retention; peptic ulceration. Monitor serum electrolytes especially bicarbonates. Patients on low Na diet. Prolonged & excessive use. Concurrent use w/ corticosteroids or Al-based gels. Renal impairment & abnormalities; cirrhosis. Women of childbearing potential. Pregnancy & lactation.

Click to view U-Lite detailed prescribing information

Use In Pregnancy & Lactation

Click to view U-Lite detailed prescribing information

Adverse Reactions

Stomach cramps, belching, flatulence, vomiting; spontaneous stomach rupture. Mild laxative effect due to incompletely absorbed tartrate component.

Click to view U-Lite detailed prescribing information

Drug Interactions

Increased renal clearance & decreased effects of lithium, acidic drugs eg, chlorpropamide, salicylates, tetracyclines, barbiturates. Prolonged t_½ & increased effects or toxicity of basic drugs eg, amphetamines, ephedrine/pseudoephedrine. Reduced or increased rate &/or extent of absorption of drugs eg, antacids, laxative, other antibiotics. Systemic alkalosis & development of Ca stones w/ antacids. Increased Al absorption w/ Al-containing antacids. Reduced solubility of quinolones eg, ciprofloxacin, norfloxacin or ofloxacin. Reduced antibacterial effect of hexamine. Additive effect w/ laxatives.

Click to view U-Lite detailed prescribing information

Storage

View U-Lite storage conditions for details to ensure optimal shelf-life.

Description

View U-Lite description for details of the chemical structure and excipients (inactive components).

Action

View U-Lite mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on the Genito-Urinary System

ATC Classification

G04BX - Other urologicals ; Used in the treatment of urological problems.

Regulatory Classification

Presentation/Packing

Form

U-Lite effervescent granules

Packing/Price

(orange flavour) 4.1 g x 12 × 1's; (orange flavour) 4.1 g x 28 × 1's

U-Lite

Manufacturer:

Winwa Medical

Distributor:

Winwa Medical